Pouw, Juliëtte N.
Olde Nordkamp, Michel A. M.
van Kempen, Tessa
Concepcion, Arno N.
van Laar, Jacob M.
van Wijk, Femke
Spierings, Julia
Leijten, Emmerik F. A.
Boes, Marianne
Article History
Received: 18 July 2022
Accepted: 22 November 2022
First Online: 30 November 2022
Change Date: 24 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-28623-y
Competing interests
: JvL received honoraria from Abbvie, AstraZeneca, Boehringer Ingelheim, Celltrion, Galapagos and Magenta, Roche, and received research grants from AstraZeneca, Boehringer Ingelheim, Roche and Thermofischer. FvW reports grants from investigator initiated studies from Regeneron, Leo Pharma, and Galapagos, a collaboration study with Takeda, and consultant/speaker fees from Takeda and Johnson&Johnson, all outside the submitted work. JS received research grants from Boehringer Ingelheim and Miltenyi. MB reports research grants from Actuate Therapeutics, Nutricia and Argenx, unrelated to the submitted work. All other authors state no conflict of interest and have no disclosures.